Location: Home
  • search
  • go
  • Relate News
  • 3/3/2022China Conditionally Approves First Recombinant Protein COVID-19 Vaccin...
  • 3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...
  • 3/3/2022Aquestive and Haisco Enter Licensing and Supply Deal for Riluzole Oral...
  • 3/3/2022Eutilex Signs MOU with OBiO for Developing Cell Therapies in China
  • 3/3/2022Lesson from China's National Negotiation of Drug Prices in 2021 (NLR)
  • 3/3/2022Domestic Chinese Checkpoint Inhibitors: A Big Threat to Western Pharm...
  • 3/2/2022FDA OKs J&J and Legend's BCMA CAR-T, Setting Stage for Showdown with B...
  • 3/2/2022Adagene and Sanofi Enter SAFEbody Multi-Target Collaboration for Nove...
  • 3/2/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (56...
  • 3/2/2022Gene Therapy Startup Grit Science Raises CNY Hundreds of Millions
  • 3/2/2022Tasly Reportedly Eyeing to Terminate License Pact with Sutro Biopharma
  • 3/2/2022The New Chinese Physicians Law Contains Provisions on Clinical Guideli...
  • 3/1/2022Financial-related Company News Digest
  • 3/1/2022Drug R&D and Product Registration News Digest February 2022 (3)
  • 3/1/2022Digestome Therapeutics Licenses Schizophrenia Drug DGX-001 for Greater...
  • 3/1/2022Heidelberg Pharma and Huadong Announce Strategic Partnership, Includin...
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • 2/26/2022CARsgen Therapeutics Opens New U.S. cGMP Facility for CAR T Production
  • 2/25/2022NMPA Announces Package Insert Revision of Proton Pump Inhibitor Drug F...
  • 2/25/2022CDE Issues the Technical Guidelines for Clinical Trials of Human Fibri...
  • 2/25/2022CDE Issues the Technical Guidance for Clinical Research of Human Rabie...
  • 2/23/2022Lepu Biopharma Launches IPO on the Main Board of HKEX
  • 2/23/202215 Category 4.1 Patent Invalidation Challenges Initiated in China afte...
  • 2/23/2022OBI and Odeon Enter $200M License Deal for China Rights of OBI-999 a...
  • 2/23/2022Kiniksa Pharma and Huadong Medicine Announce Strategic Collaboration
  • 2/23/2022New Report: Assessment of China's Oncology Drugs Market 2022-2027
  • 2/22/2022Luye Pharma and Biostar Agree to Co-market Anticancer Utidelone in Mai...
  • 2/22/2022Kexing Biopharm to Pair with AntiV BioPharma to Jointly Develop Small-...
  • 2/22/2022Stemirna gets ready for China's own mRNA Covid-19 vaccine as global mu...
  • Page:92/719 Total number of articles:21546: [First][<<] [90] [91] [92] [93] [94] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group